Background. Rhabdomyosarcoma (RMS) is a heterogeneous disease consisting of
several different histologies arising from a variety of anatomic sites. Ap
proximately half of the children who die of this tumor have failure at the
primary site of involvement, making local control an important component of
therapy. Procedure. Published literature and newly analyzed data from the
Intergroup Rhabdomyosarcoma Study Group (IRSG) regarding local control of R
MS were reviewed. Information regarding the role of various local control m
odalities for different primary disease sites is presented along with new d
irections for clinical research. Results. Local control rates For RMS avera
ge 80% for group III tumors, with large variations seen for different anato
mic sites. Important gains in functional outcome for certain sites such as
gynecologic system and bladder/prostate have been achieved by optimizing th
e use of the various treatment modalities. Local control at other sites suc
h as the chest and extremities remains a problem. Conclusions. Advances in
surgical and radiotherapy techniques coupled with multiagent chemotherapy a
re providing improved local control with decreasing morbidity. Optimal outc
ome is dependent on close collaboration between surgical, radiotherapy, and
pediatric oncology specialists. Med. Pediatr. Oncol. 35:104-109, 2000. (C)
2000 Wiley-Liss, Inc.